IL136507A0 - New arylpiperazinylalkyl-3(2h)-pyridazinones - Google Patents

New arylpiperazinylalkyl-3(2h)-pyridazinones

Info

Publication number
IL136507A0
IL136507A0 IL13650700A IL13650700A IL136507A0 IL 136507 A0 IL136507 A0 IL 136507A0 IL 13650700 A IL13650700 A IL 13650700A IL 13650700 A IL13650700 A IL 13650700A IL 136507 A0 IL136507 A0 IL 136507A0
Authority
IL
Israel
Prior art keywords
arylpiperazinylalkyl
pyridazinones
new
new arylpiperazinylalkyl
Prior art date
Application number
IL13650700A
Other languages
English (en)
Original Assignee
Faes Fabrica Espanola De Produ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faes Fabrica Espanola De Produ filed Critical Faes Fabrica Espanola De Produ
Publication of IL136507A0 publication Critical patent/IL136507A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13650700A 1999-06-04 2000-06-01 New arylpiperazinylalkyl-3(2h)-pyridazinones IL136507A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009901239A ES2162731B1 (es) 1999-06-04 1999-06-04 Nuevas arilpiperacilnilalquil-3(2h)-piridacinonas.

Publications (1)

Publication Number Publication Date
IL136507A0 true IL136507A0 (en) 2001-06-14

Family

ID=8308721

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13650700A IL136507A0 (en) 1999-06-04 2000-06-01 New arylpiperazinylalkyl-3(2h)-pyridazinones

Country Status (15)

Country Link
US (1) US6413966B1 (tr)
EP (1) EP1057820A1 (tr)
JP (1) JP2001002659A (tr)
KR (1) KR20010049474A (tr)
AU (1) AU3780100A (tr)
BR (1) BR0002578A (tr)
CA (1) CA2310873A1 (tr)
ES (1) ES2162731B1 (tr)
HR (1) HRP20000370A2 (tr)
HU (1) HUP0002132A2 (tr)
IL (1) IL136507A0 (tr)
MX (1) MXPA00005428A (tr)
NO (1) NO20002837L (tr)
PL (1) PL340490A1 (tr)
TR (1) TR200001621A3 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10036818A1 (de) * 2000-07-28 2002-02-07 Solvay Pharm Gmbh Neue N-Triazolylmethyl-Piperazinderivate als Neurokininrezeptor-Antagonisten
ATE424825T1 (de) 2001-07-20 2009-03-15 Psychogenics Inc Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten
EP4076456B1 (en) * 2019-12-19 2024-05-01 Université de Strasbourg Sigma-1 receptor ligands and therapeutic uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5001130A (en) * 1988-02-18 1991-03-19 Bristol-Myers Company Psychotropic heterobicycloalkylpiperazine derivatives
HU214320B (hu) * 1991-12-20 1998-03-02 EGIS Gyógyszergyár Rt. Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására
JP3670690B2 (ja) * 1993-10-04 2005-07-13 トーアエイヨー株式会社 ３−ピリダジノン誘導体、その製造法およびそれを含有する循環器官用剤
EP0875512A3 (en) * 1997-04-16 1999-04-07 Fabrica Espanola De Productos Quimicos Y Farmaceuticos, S.A. (Faes) New naphthylpiperazine derivatives with antipsychotic activity
CN1142148C (zh) * 1997-11-19 2004-03-17 兴和株式会社 新颖的哒嗪衍生物和含有其作为有效成分的药物

Also Published As

Publication number Publication date
JP2001002659A (ja) 2001-01-09
KR20010049474A (ko) 2001-06-15
EP1057820A1 (en) 2000-12-06
HRP20000370A2 (en) 2001-06-30
BR0002578A (pt) 2001-01-02
NO20002837L (no) 2000-12-05
MXPA00005428A (es) 2002-06-04
PL340490A1 (en) 2000-12-18
TR200001621A2 (tr) 2001-07-23
US6413966B1 (en) 2002-07-02
AU3780100A (en) 2000-12-07
NO20002837D0 (no) 2000-06-02
CA2310873A1 (en) 2000-12-04
ES2162731B1 (es) 2003-02-16
HUP0002132A2 (hu) 2002-11-28
ES2162731A1 (es) 2002-01-01
TR200001621A3 (tr) 2001-07-23
HU0002132D0 (en) 2000-08-28

Similar Documents

Publication Publication Date Title
IL148218A0 (en) New phenylpiperazines
IL151439A0 (en) Power-cord connection set
GB0014634D0 (en) Loudspeaker
GB9911156D0 (en) Loudspeakers
GB9910220D0 (en) Loudspeakers
IL136507A0 (en) New arylpiperazinylalkyl-3(2h)-pyridazinones
GB2358545B (en) Loudspeaker
IL143530A0 (en) Pyridazinone derivatives
GB9909535D0 (en) Loudspeakers
GB0018831D0 (en) Loudspeaker
GB9903044D0 (en) Loudspeakers
GB0130875D0 (en) Loudspeaker
GB9903377D0 (en) Amphibious-tricycle (amphi-trike)
GB9902750D0 (en) Loudspeakers
GB9928456D0 (en) Loudspeakers
EP1193999A4 (en) SPEAKER
GB0209536D0 (en) Loudspeakers
GB0013137D0 (en) Loudspeaker
GB2368486B (en) Loudspeaker
GB0027866D0 (en) Hydrogen
GB9917858D0 (en) Pyrazoles
EG22401A (en) Set 3c1-strong
GB9911980D0 (en) Loudspeaker
GB9902108D0 (en) Loudspeaker
GB9924525D0 (en) Wallpapering aid